Full Name | Taylor Wolfe |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 429 Arch St, Carlisle, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598287542 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SL013492 (Pennsylvania) | Secondary |
235Z00000X | Speech-language Pathologist | 07795 (Maryland) | Primary |
Provider Name | Fox Rehabilitation Services Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1326092503 PECOS PAC ID: 0143133009 Enrollment ID: O20040220000258 |
News Archive
Eli Lilly and Company today provided an update on the next steps planned for solanezumab, its Phase 3 monoclonal antibody being studied as a potential therapy for patients with mild Alzheimer's disease.
Research into the natural process of cell death, its role in the development of blood cancers and harnessing cell death to improve cancer therapies has seen a Walter and Eliza Hall Institute research team from Melbourne, Australia, awarded a grant of more than $6 million by the US-based Leukemia & Lymphoma Society.
A selection of health policy news from Iowa, Oregon, California, Oregon, Maryland, Connecticut, Kansas and Texas.
Case Western Reserve is one of two universities in the country selected to lead a $27.3 million international effort to identify the causes of a mysterious and deadly phenomenon that strikes people with epilepsy without warning.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Taylor Wolfe, 429 Arch St, Carlisle, PA 17013-3806 Ph: () - | Taylor Wolfe, 429 Arch St, Carlisle, PA 17013-3806 Ph: (717) 201-0379 |
News Archive
Eli Lilly and Company today provided an update on the next steps planned for solanezumab, its Phase 3 monoclonal antibody being studied as a potential therapy for patients with mild Alzheimer's disease.
Research into the natural process of cell death, its role in the development of blood cancers and harnessing cell death to improve cancer therapies has seen a Walter and Eliza Hall Institute research team from Melbourne, Australia, awarded a grant of more than $6 million by the US-based Leukemia & Lymphoma Society.
A selection of health policy news from Iowa, Oregon, California, Oregon, Maryland, Connecticut, Kansas and Texas.
Case Western Reserve is one of two universities in the country selected to lead a $27.3 million international effort to identify the causes of a mysterious and deadly phenomenon that strikes people with epilepsy without warning.
› Verified 4 days ago
Nichole Jennifer Reynolds, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Jennifer Ct, Suite A, Carlisle, PA 17015 Phone: 717-243-0271 Fax: 717-243-0531 | |
Gail Yvonne Kemeny, M.S. CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 940 Walnut Bottom Rd, Carlisle, PA 17015 Phone: 717-249-0085 Fax: 717-249-0647 | |
Abbie Rose Lookingbill, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Longsdorf Way, Carlisle, PA 17015 Phone: 717-309-1889 | |
Hannah Yohn, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 417 Village Dr Ste 4, Carlisle, PA 17015 Phone: 717-245-0610 | |
Heidi Ann Stearns, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Longsdorf Way, Carlisle, PA 17015 Phone: 717-462-4028 | |
Stephanie Mcgarrell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 271 Hoy Rd, Carlisle, PA 17013 Phone: 717-258-8431 | |
Summer Dacheux, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 804 Belvedere St, Carlisle, PA 17013 Phone: 717-512-2841 |